2017 Annual Meeting | C123 - Myelopathies I: Inflammatory and Vascular Etiologies

Date Tuesday 04/25/17

Time 01:00 PM - 03:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Benjamin M. Greenberg, MD, FAAN

Topic(s)

Learning Objectives Participants should be able to recognize the wide spectrum of myelopathies and develop a practical and systematic approach toward the investigation and management of these disorders; and be aware of the recent advances related to spinal dural arteriovenous fistulas, neuromyelitis optica, multiple sclerosis and other autoimmune disorders, copper deficiency, and other metabolic and toxic disorders.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
01:00 PM - 01:10 PM	Luncheon	Introduction Benjamin M. Greenberg, MD, FAAN
01:10 PM - 01:40 PM	Speaker	Transverse Myelitis Benjamin M. Greenberg, MD, FAAN
01:40 PM - 01:45 PM	Q&A	Questions and Answers Benjamin M. Greenberg, MD, FAAN
01:45 PM - 02:15 PM	Speaker	Vascular Myelopathies Philippe Gailloud, MD
02:15 PM - 02:20 PM	Q&A	Questions and Answers Philippe Gailloud, MD
02:20 PM - 02:50 PM	Speaker	Hereditary Myelopathies John K. Fink, MD
02:50 PM - 02:55 PM	Q&A	Questions and Answers John K. Fink, MD
02:55 PM - 03:00 PM	Closing Remarks	Closing Remarks Benjamin M. Greenberg, MD, FAAN

Faculty Disclosures
John K. Fink, MD	No disclosure on file
Benjamin M. Greenberg, MD, FAAN	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Husch Blackwell. Dr. Greenberg has stock in GenrAb. Dr. Greenberg has stock in Clene. The institution of Dr. Greenberg has received research support from Anokion. The institution of Dr. Greenberg has received research support from Regeneron. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Philippe Gailloud, MD	Dr. Gailloud has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerenovus. Dr. Gailloud has received stock or an ownership interest from ArtVentive. The institution of Dr. Gailloud has received research support from Siemens Medical.

��ɫ��

��ɫ��